Neuralink operates in the neurotechnology and medical device sectors, developing implantable brain-computer interfaces (BCIs) that translate neural signals into digital commands. The company's work spans neuroscience, microscale electronics, and biomedical engineering. Its technology is designed to enable direct control of computers and mobile devices through thought.
The company's primary product is the N1 implant, a fully implantable and cosmetically invisible BCI. It is intended to help individuals with severe neurological conditions interact with digital devices. Neuralink's approach involves miniaturising complex electronics for long-term implantation in the human brain.
Neuralink sits at the intersection of advanced neuroscience and engineering, working on some of the most technically challenging problems in the deeptech space. Its focus on translating neural activity into actionable digital output places it within a rapidly evolving field of neurotechnology research and development.
